Nexaph peptides represent a groundbreaking clinical strategy targeting illness progression. These modified compounds leverage the distinct properties of short peptide sequences to influence cellular activities involved in swelling, scarring, and cancer development. Investigations demonstrate their capability for treating a spectrum of chronic ailme